IPW
NVO

Impact Partnership Wealth’s Novo Nordisk NVO Stock Holding History

Impact Partnership Wealth’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-170
Closed -$13.8K – 1142
2023
Q2 		$13.8K Buy
+170
New +$13.9K ﹤0.01% 387

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Impact Partnership Wealth's NVO Position: Q3 2023 in Review

Impact Partnership Wealth sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 170 shares — an estimated $13.8K sold.

Impact Partnership Wealth first reported a position in NVO in Q2 2023 and held it in 1 quarter. The position peaked at $13.8K in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Impact Partnership Wealth reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 170 Novo Nordisk shares in Q3 2023, an estimated $13.8K.
  • Impact Partnership Wealth first reported a position in Novo Nordisk in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Novo Nordisk position peaked at $13.8K in Q2 2023.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.